Privately, some drug industry lobbyists said they hoped to nudge Democrats toward a separate drug pricing effort that came out of the Senate Finance Committee with some bipartisan support last Congress. (Photo: Shutterstock)
Congress hopes to pass a massive infrastructure improvement package, and the pharmaceutical industry may end up footing part of the bill.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
